Shilpa Medicare gets EIR from USFDA for Raichur facilities


“The USFDA has issued an EIR for the company#39;s Active Pharmaceutical Ingredient (API) manufacturing facilities located at Raichur, Karnataka which was inspected between December 12-16, 2016. The inspection has now been closed by the USFDA,” Shilpa Medicare said in a BSE filing.
Source: Top News